Wealthspan Partners’s Boston Scientific BSX Stock Holding History

Wealthspan Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,683	Closed	-$231K	–	130
2026 Q1	$231K	Hold	3,683	–	–	0.08%	111
2025 Q4	$351K	Hold	3,683	–	–	0.13%	92
2025 Q3	$360K	Hold	3,683	–	–	0.14%	91
2025 Q2	$396K	Hold	3,683	–	–	0.16%	82
2025 Q1	$372K	Hold	3,683	–	–	0.17%	80
2024 Q4	$329K	Hold	3,683	–	–	0.16%	85
2024 Q3	$309K	Hold	3,683	–	–	0.15%	85
2024 Q2	$284K	Hold	3,683	–	–	0.16%	82
2024 Q1	$252K	Hold	3,683	–	–	0.15%	87
2023 Q4	$213K	Buy	+3,683	New	+$197K	0.15%	81

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wealthspan Partners's BSX Position: Q2 2026 in Review

Wealthspan Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,683 shares — an estimated $231K sold.

Wealthspan Partners first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $396K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Wealthspan Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Wealthspan Partners sold 3,683 Boston Scientific shares in Q2 2026, an estimated $231K.
Wealthspan Partners first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
Wealthspan Partners's Boston Scientific position peaked at $396K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wealthspan Partners's 13F filing for Q2 2026, filed 6 Aug 2026.